HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase
Annika W Nonboe1, Oliver Krigslund1, Christoffer Soendergaard1,2
1Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen North, Denmark.
Abstract:
It has recently been shown that hepatocyte growth factor activator inhibitor-2 (HAI-2) is able to suppress carcinogenesis induced by overexpression of matriptase, as well as cause regression of individual established tumors in a mouse model system. However, the role of HAI-2 is poorly understood. In this study, we describe 3 mutations in the binding loop of the HAI-2 Kunitz domain 1 (K42N, C47F and R48L) that cause a delay in the SEA domain cleavage of matriptase, leading to accumulation of non-SEA domain cleaved matriptase in the endoplasmic reticulum (ER). We suggest that, like other known SEA domains, the matriptase SEA domain auto-cleaves and reflects that correct oligomerization, maturation, and/or folding has been obtained. Our results suggest that the HAI-2 Kunitz domain 1 mutants influence the flux of matriptase to the plasma membrane by affecting the oligomerization, maturation and/or folding of matriptase, and as a result the SEA domain cleavage of matriptase. Two of the HAI-2 Kunitz domain 1 mutants investigated (C47F, R48L and C47F/R48L) also displayed a reduced ability to proteolytically silence matriptase. Hence, HAI-2 separately stabilizes matriptase, regulates the secretory transport, possibly via maturation/oligomerization and inhibits the proteolytic activity of matriptase in the ER, and possible throughout the secretory pathway.
Insights
Hepatocyte growth factor activator inhibitor-2 (HAI-2) mutations delay matriptase cleavage, affecting its transport and activity. This research clarifies HAI-2's role in regulating matriptase, crucial for cancer suppression.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Hepatocyte growth factor activator inhibitor-2 (HAI-2) suppresses matriptase-induced carcinogenesis and promotes tumor regression.
- The precise mechanisms underlying HAI-2's function remain incompletely understood.
Purpose of the Study:
- To investigate the impact of specific HAI-2 Kunitz domain 1 mutations on matriptase processing and function.
- To elucidate HAI-2's role in regulating matriptase maturation, transport, and proteolytic activity.
Main Methods:
- Introduction of three mutations (K42N, C47F, R48L) into the HAI-2 Kunitz domain 1.
- Analysis of matriptase SEA domain cleavage, endoplasmic reticulum (ER) accumulation, and proteolytic silencing.
- Assessment of matriptase oligomerization, maturation, and folding.
Main Results:
- Mutant HAI-2 proteins delayed SEA domain cleavage of matriptase, causing its accumulation in the ER.
- Mutations affected matriptase oligomerization, maturation, and/or folding, influencing its transport to the plasma membrane.
- Specific HAI-2 mutants exhibited reduced ability to proteolytically inhibit matriptase.
Conclusions:
- HAI-2 plays a multifaceted role: stabilizing matriptase, regulating its transport via maturation/oligomerization, and inhibiting its proteolytic activity.
- These findings provide new insights into the regulatory mechanisms of matriptase by HAI-2 within the secretory pathway.
- Understanding these interactions is critical for developing targeted cancer therapies.
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Destabilization of Microtubules
Drugs that Stabilize Microtubules
Microtubule Instability
Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Role of Matrix Metalloproteases in Degradation of ECM
A...


